{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:20:49Z","timestamp":1783117249708,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2320-B-255-006-MY3"],"award-info":[{"award-number":["111-2320-B-255-006-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2811-B-255-002"],"award-info":[{"award-number":["111-2811-B-255-002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.heliyon.2023.e18422","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T04:15:59Z","timestamp":1689740159000},"page":"e18422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Design and evaluation of oral formulation for apixaban"],"prefix":"10.1016","volume":"9","author":[{"given":"Chien-Chiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-1702","authenticated-orcid":false,"given":"Yu-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Chien","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-8254","authenticated-orcid":false,"given":"Yu-Chia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Fan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Rong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Rung","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5780-3977","authenticated-orcid":false,"given":"Tsong-Long","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.heliyon.2023.e18422_bib1","first-page":"2517","article-title":"Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people, Ir","volume":"191","author":"Erdem","year":"2022","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.heliyon.2023.e18422_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e18422_bib3","first-page":"252","article-title":"Assessment and management of the left atrial appendage thrombus in patients with nonvalvular atrial fibrillation","volume":"34","author":"Zhan","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e18422_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2459\/JCM.0000000000000735","article-title":"Nonvalvular atrial fibrillation in high-hemorrhagic-risk patients: state of the art of percutaneous left atrial appendage occlusion","volume":"20","author":"Merella","year":"2019","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.heliyon.2023.e18422_bib5","first-page":"807","article-title":"Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants","volume":"13","author":"Garkina","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e18422_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with Atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"S5","key":"10.1016\/j.heliyon.2023.e18422_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000381372","article-title":"Pediatric dysphagia: physiology, assessment, and management","volume":"66","author":"Dodrill","year":"2015","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.heliyon.2023.e18422_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/geriatrics5010009","article-title":"Optimising medicines administration for patients with dysphagia in hospital: medical or nursing responsibility?","volume":"5","author":"Wright","year":"2020","journal-title":"Geriatrics"},{"key":"10.1016\/j.heliyon.2023.e18422_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6618934","article-title":"Formulation and quality control of orally disintegrating tablets (ODTs): recent advances and perspectives","volume":"2021","author":"Ghourichay","year":"2021","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2023.e18422_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1248\/yakushi.14-00228-3","article-title":"Clinical functionality required for orally disintegrating tablets selected as the next generation type","volume":"135","author":"Namiki","year":"2015","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.heliyon.2023.e18422_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2015.03.012","article-title":"Oral films: current status and future perspectives II - intellectual property, technologies and market needs","volume":"206","author":"Borges","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e18422_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1517\/17425247.2011.553217","article-title":"Advances in orodispersible films for drug delivery","volume":"8","author":"Hoffmann","year":"2011","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.heliyon.2023.e18422_bib13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijbiomac.2021.02.180","article-title":"A review on orally disintegrating films (ODFs) made from natural polymers such as pullulan, maltodextrin, starch, and others","volume":"178","author":"Pacheco","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e18422_bib14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/pharmaceutics13081206","article-title":"An updated overview of the emerging role of patch and film-based buccal delivery systems","volume":"13","author":"Jacob","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2023.e18422_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jconrel.2022.10.058","article-title":"Buccal films: a review of therapeutic opportunities, formulations & relevant evaluation approaches","volume":"352","author":"Shipp","year":"2022","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18422_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jsps.2015.02.024","article-title":"Orally disintegrating films: a modern expansion in drug delivery system","volume":"24","author":"Irfan","year":"2016","journal-title":"Saudi Pharmaceut. J."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e18422_bib17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/ph15070844","article-title":"An insight into preparatory methods and characterization of orodispersible film-A review","volume":"15","author":"Salawi","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18422_bib18","first-page":"190","article-title":"Characterization and optimization of mouth dissolving film of an anticoagulant drug: apixaban","volume":"7","author":"Shah","year":"2022","journal-title":"IJPRA"},{"key":"10.1016\/j.heliyon.2023.e18422_bib19","series-title":"[Online available] Eliquis Tablets","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18422_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/2230-973X.114897","article-title":"Orally dissolving strips: a new approach to oral drug delivery system","volume":"3","author":"Bala","year":"2013","journal-title":"Int. J. Pharm. Investig."},{"issue":"17","key":"10.1016\/j.heliyon.2023.e18422_bib21","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.3390\/ma14174872","article-title":"Success depends on your backbone-about the use of polymers as essential materials forming orodispersible films","volume":"14","author":"Olechno","year":"2021","journal-title":"Materials"},{"key":"10.1016\/j.heliyon.2023.e18422_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/adt.2020.1052","article-title":"Cocrystals of apixaban with improved solubility and permeability: formulation, physicochemical characterization, pharmacokinetic evaluation, and computational studies","volume":"19","author":"Madan","year":"2021","journal-title":"Assay Drug Dev. Technol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18422_bib23","first-page":"559","article-title":"Deacetylation of chitin and the properties of chitosan films with various deacetylation degrees","volume":"13","author":"Potivas","year":"2014","journal-title":"CM"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18422_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/gels9020147","article-title":"Preparation, characterization, and evaluation of cytotoxicity of fast dissolving hydrogel based oral thin films containing pregabalin and methylcobalamin","volume":"9","author":"\u00d6zakar","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.heliyon.2023.e18422_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13318-011-0037-x","article-title":"Grossman, preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor","volume":"36","author":"He","year":"2011","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.heliyon.2023.e18422_bib26","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1124\/dmd.108.025981","article-title":"Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans","volume":"37","author":"Zhang","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.heliyon.2023.e18422_bib27","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2165\/11596820-000000000-00000","article-title":"Apixaban: first global approval","volume":"71","author":"Watson","year":"2011","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18422_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s40262-019-00775-z","article-title":"Apixaban: a clinical pharmacokinetic and pharmacodynamic review","volume":"58","author":"Byon","year":"2019","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18422_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1573403X12666160720092024","article-title":"Novel oral anticoagulants in atrial fibrillation: update on apixaban","volume":"13","author":"Mezue","year":"2017","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.heliyon.2023.e18422_bib30","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jps.24274","article-title":"Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the intellicap\u00ae system","volume":"104","author":"Koziolek","year":"2015","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2023.e18422_bib31","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0016-5085(86)90873-5","article-title":"Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency","volume":"90","author":"Ovesen","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2023.e18422_bib32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1023\/A:1015877011807","article-title":"Preformulation studies involving moisture uptake in solid dosage forms","volume":"8","author":"Heidemann","year":"1991","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.heliyon.2023.e18422_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/ars.2012.4623","article-title":"Studies of mitochondrial and nonmitochondrial sources implicate nicotinamide adenine dinucleotide phosphate oxidase(s) in the increased skeletal muscle superoxide generation that occurs during contractile activity","volume":"18","author":"Sakellariou","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.heliyon.2023.e18422_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2016.06.020","article-title":"Influence of variation in molar ratio on co-amorphous drug-amino acid systems","volume":"107","author":"Jensen","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.heliyon.2023.e18422_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120802","article-title":"The influence of moisture on the storage stability of co-amorphous systems","volume":"605","author":"Liu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2023.e18422_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1021\/mp9002283","article-title":"Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture","volume":"7","author":"Rumondor","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.heliyon.2023.e18422_bib37","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/jps.20411","article-title":"Role of water in the physical stability of solid dosage formulations","volume":"94","author":"Airaksinen","year":"2005","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2023.e18422_bib38","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1366\/13-07329","article-title":"Polymorph characterization of active pharmaceutical ingredients (APIs) using low-frequency Raman spectroscopy","volume":"68","author":"Larkin","year":"2014","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.heliyon.2023.e18422_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fphar.2019.00014","article-title":"Interactions between paracetamol and hypromellose in the solid state","volume":"10","author":"Leyk","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18422_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.32553\/ijpba.v7i2.117","article-title":"Formulation and evaluation of sublingual films of apixaban","volume":"7","author":"Joshi","year":"2019","journal-title":"IJPBA"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402305630X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402305630X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:40:48Z","timestamp":1783114848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402305630X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S240584402305630X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18422","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and evaluation of oral formulation for apixaban","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e18422"}}